Jacob Roorda
CIK 1344148 · View on SEC EDGAR ↗
First SEC filing: Feb. 25, 2019 · Latest: Feb. 25, 2019
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 3, 2023 | EPSN | A | 9,804 | — | — | 106,804 Direct | +10.11% | Acquired | (price as of 2026-08-20) |
| April 6, 2022 | EPSN | A | 6,600 | — | — | 97,000 Direct | +7.30% | Acquired | (price as of 2026-08-20) |
| Aug. 25, 2021 | EPSN | A | 8,000 | — | — | 115,400 Indirect | +7.45% | Acquired | (price as of 2026-08-20) |
| Dec. 31, 2020 | EPSN | A | 11,000 | — | — | 107,400 Indirect | +11.41% | Acquired | (price as of 2026-08-20) |
| Dec. 31, 2019 | EPSN | M | 5,500 | — | — | 8,500 Direct | -39.29% | Disposed | (price as of 2026-08-20) |
| Dec. 31, 2019 | EPSN | M | 5,500 | — | — | 75,900 Direct | +7.81% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 31, 2019 | EPSN | Restricted Stock Grant | Common Shares (5,500) | — | — | 5,500 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 25, 2019 | EPSN | Common Shares | 42,900 | Direct |
| Feb. 25, 2019 | EPSN | Common Shares | 25,000 | Indirect |
| Feb. 25, 2019 | EPSN | Option (right to buy)→ Common Shares (12,500) | 12,500 | Direct |
| Feb. 25, 2019 | EPSN | Restricted Stock Grant→ Common Shares (5,000) | 5,000 | Direct |
| Feb. 25, 2019 | EPSN | Restricted Stock Grant→ Common Shares (9,000) | 9,000 | Direct |